Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 12/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 12/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | CMA1 | P23946 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12366364 | 0.89 | GRIN1 (0.39) | GRIN1GRIN2B | |
| SCHEMBL12366351 | 0.89 | AR (0.43) | GRIN1GRIN2BGABRA1GABRA5OPRK1 | |
| SCHEMBL12366256 | 0.89 | POLB (0.38) | AR | |
| SCHEMBL12366233 | 0.88 | CNR1 (0.42) | CMA1CTRC | |
| SCHEMBL12366250 | 0.86 | MAPT (0.40) | AR | |
| SCHEMBL12366418 | 0.85 | MAPT (0.42) | GRIN1GRIN2B | |
| SCHEMBL12366286 | 0.85 | MAPT (0.45) | GRIN1GRIN2B | |
| SCHEMBL12366740 | 0.85 | PTGS2 (0.35) | CMA1CTRC | |
| SCHEMBL12366472 | 0.85 | LMNA (0.45) | — | |
| SCHEMBL12366288 | 0.84 | MDM2 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7998986-B2 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS PATENT COMPANY LLC (US) | 2011-08-16 | — | — | US | disclosed |